Recurrence of Punctate Inner Choroidopathy with an Intravitreal Dexamethasone Implant.
10.3341/jkos.2017.58.11.1282
- Author:
Min Ho SHIN
1
;
Hyun Ji KANG
;
In Young CHUNG
Author Information
1. Department of Ophthalmology, Gyeongsang National University School of Medicine, Jinju, Korea. in0chung@hanmail.net
- Publication Type:Case Report
- Keywords:
Intravitreal bevacizumab;
Intravitreal dexamethasone implant;
Punctate inner choroidopathy;
Systemic steroid
- MeSH:
Angiography;
Bevacizumab;
Choroidal Neovascularization;
Dexamethasone*;
Edema;
Female;
Hand;
Humans;
Indocyanine Green;
Recurrence*;
Tomography, Optical Coherence;
Visual Acuity;
Young Adult
- From:Journal of the Korean Ophthalmological Society
2017;58(11):1282-1288
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: To report a case of punctate inner choroidopathy (PIC) treated with an intravitreal dexamethasone implant due to side effects of systemic steroid treatment. CASE SUMMARY: A 23-year-old highly myopic female who presented with PIC in her right eye was treated with an intravitreal dexamethasone implant due to side effects of systemic steroid treatment including facial edema and sleep disturbances. Three months after the implant she complained of severe acute visual disturbances in her right eye. Her visual acuity was classified as hand movement. Choroidal neovascularization (CNV) was observed on optical coherence tomography and indocyanine green angiography revealed more multiple hypofluorescent lesions compared to the initial visit. Six months after the systemic steroid and intravitreal bevacizumab injection treatments, visual acuity in right eye improved and the CNV disappeared. CONCLUSIONS: This report describes a case of PIC after, treatment with an intravitreal dexamethasone implant due to the side effects of systemic steroid treatment, which recurred with complications.
